ALAVERT ALLERGY- loratadine tablet, orally disintegrating
Haleon US Holdings LLC

----------

Drug Facts

ACTIVE INGREDIENT (IN EACH TABLET)

Loratadine 10 mg

PURPOSE

Antihistamine

USES

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

runny nose
sneezing
itchy, watery eyes
itching of the nose or throat

WARNINGS

Do not use

if you have ever had an allergic reaction to this product or any of its ingredients

Ask a doctor before use if you have

liver or kidney disease. Your doctor should determine if you need a different dose.

When using this product

do not use more than directed. Taking more than recommended may cause drowsiness.

Stop use and ask a doctor if

an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

DIRECTIONS

tablet melts in mouth. Can be taken with or without water.

Age	Dose
adults and children 6 years and over	1 tablet daily; do not use more than 1 tablet daily
children under 6	ask a doctor
consumers who have liver or kidney disease	ask a doctor

OTHER INFORMATION

Phenylketonurics:Contains Phenylalanine 8.4 mg per tablet
store at 20-25ºC (68-77ºF)
keep in a dry place

INACTIVE INGREDIENTS

Alavert Allergy Fresh Mint

anhydrous citric acid, aspartame, colloidal silicon dioxide, corn syrup solids, crospovidone, magnesium stearate, mannitol, microcrystalline cellulose, modified starch, natural and artificial flavors, sodium bicarbonate

Alavert Allergy Citrus Burst

anhydrous citric acid, aspartame, butylated hydroxyanisole, colloidal silicon dioxide, corn syrup solids, crospovidone, dextrin, ferric oxides, magnesium stearate, maltodextrin, mannitol, microcrystalline cellulose, modified starch, natural and artificial flavors, sodium bicarbonate

QUESTIONS OR COMMENTS?

call weekdays from 9 AM to 5 PM EST at 1-800-ALAVERT (1-800-252-8378)

PRINCIPAL DISPLAY PANEL

The product packaging shown below represents a sample of that currently in use. Additional packaging may also be available.

ALAVERT allergy Fresh Mint

Loratadine Orally Disintegrating Tablet, 10 mg, Antihistamine

18 Orally Disintegrating Tablets

TASTES GREAT!

Melts in your Mouth!

Non-Drowsy* Allergy Relief

*When taken as directed. See Drug Facts Panel.

24 HOUR Relief of

Sneezing
Runny Nose
Itchy, Watery Eyes
Itching of Nose & Throat

Compare to Claritin †& SAVE!

†Claritin is a registered trademark of Schering Corporation

Alavert Allergy Fresh Mint Packaging

PRINCIPAL DISPLAY PANEL

ALAVERT allergy Citrus Burst

Loratadine Orally Disintegrating Tablet, 10 mg, Antihistamine

18 Orally Disintegrating Tablets

TASTES GREAT!

Melts in your Mouth!

Non-Drowsy* Allergy Relief

*When taken as directed. See Drug Facts Panel.

24 HOUR Relief of

Sneezing
Runny Nose
Itchy, Watery Eyes
Itching of Nose & Throat

Compare to Claritin† & SAVE!

†Claritin is a registered trademark of Schering Corporation

Alavert Allergy Citrus Burst Packaging

ALAVERT ALLERGY
loratadine tablet, orally disintegrating

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:0573-2620
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN)	LORATADINE	10 mg

Ingredient Name	Strength
Inactive Ingredients
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
ASPARTAME (UNII: Z0H242BBR1)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
CORN SYRUP (UNII: 9G5L16BK6N)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MANNITOL (UNII: 3OWL53L36A)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
SODIUM BICARBONATE (UNII: 8MDF5V39QO)

Product Characteristics
Color	white (off white)	Score	no score
Shape	ROUND (beveled tablet)	Size	14mm
Flavor	MINT	Imprint Code	A;24
Contains

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:0573-2620-19	18 in 1 CARTON	12/19/2002
1		1 in 1 BLISTER PACK; Type 0: Not a Combination Product
2	NDC:0573-2620-01	50 in 1 BOX	12/19/2002
2		1 in 1 POUCH; Type 0: Not a Combination Product
3	NDC:0573-2620-65	60 in 1 CARTON	12/19/2002
3		1 in 1 BLISTER PACK; Type 0: Not a Combination Product
4	NDC:0573-2620-71	1500 in 1 BOX	12/19/2002
4		1 in 1 POUCH; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
NDA	NDA021375	12/19/2002

ALAVERT ALLERGY
loratadine tablet, orally disintegrating

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:0573-2621
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN)	LORATADINE	10 mg

Ingredient Name	Strength
Inactive Ingredients
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
ASPARTAME (UNII: Z0H242BBR1)
BUTYLATED HYDROXYANISOLE (UNII: REK4960K2U)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
CORN SYRUP (UNII: 9G5L16BK6N)
CROSPOVIDONE (120 .MU.M) (UNII: 68401960MK)
ICODEXTRIN (UNII: 2NX48Z0A9G)
FERRIC OXIDE RED (UNII: 1K09F3G675)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MALTODEXTRIN (UNII: 7CVR7L4A2D)
MANNITOL (UNII: 3OWL53L36A)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
SODIUM BICARBONATE (UNII: 8MDF5V39QO)

Product Characteristics
Color	orange (an orange flat faced tablet)	Score	no score
Shape	ROUND (beveled tablet)	Size	14mm
Flavor	CITRUS (orange mint)	Imprint Code	A;24
Contains

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:0573-2621-65	60 in 1 CARTON	12/19/2002
1		1 in 1 BLISTER PACK; Type 0: Not a Combination Product
2	NDC:0573-2621-19	18 in 1 CARTON	12/19/2002
2		1 in 1 BLISTER PACK; Type 0: Not a Combination Product
3	NDC:0573-2621-13	12 in 1 CARTON	12/19/2016
3		1 in 1 BLISTER PACK; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
NDA	NDA021375	12/19/2002

Labeler - Haleon US Holdings LLC (079944263)

Revised: 3/2024

Document Id: 142fa1bd-2b3f-0a65-e063-6294a90a2138

Set id: f45af3e4-5dd5-ea0a-c47c-8d68a1249158

Version: 13

Effective Time: 20240321

Haleon US Holdings LLC